
Image via discovered:nst.com.my
Last updated
L'Oreal: Ma Activity
L'Oreal acquired majority stake in Indian beauty and personal care startup Innovist, which operates brands including Bare Anatomy, Chemist at Play, SunScoop, and Vinci Botanicals. Founding team continues as minor stakeholders.
Source: discovered:nst.com.my
The leadership read
L'Oreal has made a structural commitment to India's domestic BPC market that goes well beyond a distribution agreement or a brand licensing play. Acquiring a majority stake in a multi-brand roll-up — with full buyout rights secured over minority shareholders — means L'Oreal is now on the hook for integrating four distinct brand architectures, each with separate consumer positioning, formulation logic, and D2C channel DNA, into a global P&L. The founding team remaining as minor stakeholders preserves institutional brand knowledge in the near term, but the consolidation of Innovist's revenues from deal close creates immediate financial and operational reporting obligations that the existing India structure was not built around. This is one of 12 M&A signals we have tracked across sectors in the last 90 days, though the India BPC corridor is notably concentrated relative to the broader deal set. The comparable strategic logic here runs closer to multinationals building local-brand portfolios in high-growth emerging markets than to the PE-led SaaS or logistics consolidation dominating the wider signal set. The pattern in India BPC specifically — where Mamaearth, Minimalist, and Plum have each attracted strategic or institutional attention — points to a category where incumbents are acquiring local brand equity they cannot build organically fast enough to match digitally-native competitors on formulation relevance and community trust. Companies executing this kind of roll-up integration in emerging-market BPC face concentrated demand for commercial leadership that can manage brand independence within a global governance structure, alongside operations and supply-chain depth capable of scaling D2C-first brands through organized retail without destroying margin. Cross-functional product leadership that bridges dermatological credibility with mass-market distribution is the functional area where the market is thinning fastest.
Market context: Backdrop: a 104.2 (Hot) Talent Market Index (down 1.8 on the month) with Asia activity steady (-1pts).
L'Oreal: 2 signals in the last 90 days; 0.2% of MitchelLake's Asia signal flow; 4 tracked across 75 days.
Also at L'Oreal →
More signals across Asia
Ma Activity · Asia
Nykaa →Nykaa's board approved acquisition of 51% stake in D2C skincare brand Aminu Wellness for ₹32 Cr. Aminu reported ₹19.4 Cr revenue in FY26 and manufactures cosmetics in-house.
Ma Activity · Asia
Maybank →Maybank agreed to acquire the remaining 30.95% stake in Maybank Ageas Holdings Bhd from Ageas Insurance International NV for RM4.83 billion, moving toward full ownership of the joint venture. Acquisition is subject to Bank Negara Malaysia approval.
Ma Activity · Asia
Zuellig Pharma →Zuellig Pharma acquired all rights, trademarks, marketing authorizations, and manufacturing know-how for Cialis® (Tadalafil) from Eli Lilly in Singapore, expanding ownership to 12 Asian markets. The acquisition includes both the ED and BPH indications.
Ma Activity · Asia
Capital Group →Capital Group acquired a 1.5% stake in IIFL Finance for ₹374.02 crore at ₹590 per share
“will be instrumental as we continue to expand in the region”
Ma Activity · Asia
Peak XV Partners →Peak XV Partners divested ₹139 Cr (~$16.7M USD) in Go Digit shares via block deal, marking the second major stake reduction in two months (₹100 Cr sold in June). This follows CCI approval of Go Digit Infoworks Services merger with Go Digit General Insurance.
Ma Activity · Asia
WestBridge →WestBridge Capital is considering a sale of its 40% stake in Star Health Insurance, having engaged financial advisers to evaluate the transaction.
Intelligence powered by Autonodal ↗
